Core Therapeutics LLC is categorized under Research and Development Laboratories in Lexington, KY and active since 2008.
Core Therapeutics LLC was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Mark Leggas at the company’s single location by writing to 145 Graham Avenue, Lexington, Kentucky KY 40506 or by phoning (859) 327-1341. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Core Therapeutics LLC |
Contact Person: | Mark Leggas |
Address: | 145 Graham Avenue, Lexington, Kentucky 40506 |
Phone Number: | (859) 327-1341 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Research and Development Laboratories |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Core Therapeutics LLC was started in 2008 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mark Leggas for inquiries that concern Core Therapeutics LLC by calling the company number (859) 327-1341, as your correspondence is most welcome. Additionally, the physical location of the single location of Core Therapeutics LLC can be found at the coordinates 38.036225,-84.506544 as well as the street address 145 Graham Avenue in Lexington, Kentucky 40506.
For its online presence, you may visit Core Therapeutics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.